Pedro Carvalho, MD

Center for Coronary Artery Disease International Scholar

Pedro E.P. Carvalho, MD joined the Center of Coronary Artery Disease as MHIF's inaugural Raymond Ames and Barbara Thorndike International Scholar. In his role, Dr. Carvalho will support expansion of CCAD research to the areas of intracoronary imaging, coronary physiology, microvascular disease and CT guided PCI, in addition to the existing body of research studies.

Originally from Belo Horizonte, Minas Gerais, Brazil, Pedro graduated from medical school in December 2023 and received his MD from the Federal University of Minas Gerais, Brazil. During medical school, he worked as a research assistant at the Hospital das Clínicas of the Federal University of Minas Gerais, contributing to research groups focused on improving outcomes in patients with rheumatic heart disease.

Pedro has published both as first and contributing author systematic review and meta-analysis projects in leading cardiology journals such as JACC, IJC and CCI, as well as presented at ACC Latin America, European Society of Cardiology, and other local congresses in Brazil. Additionally, he has experience as an instructor for statistical methods in meta-analysis through an online course attended by students from more than 40 countries.

Back to Coronary Team Back to Current Scholars

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.